Cidara Therapeutics Ownership | Who Owns Cidara Therapeutics?
Cidara Therapeutics Ownership Summary
Cidara Therapeutics is owned by 27.96% institutional investors, 0.72% insiders, and 71.32% retail investors. Ra capital management is the largest institutional shareholder, holding 21.65% of CDTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.55% of its assets in Cidara Therapeutics shares.
CDTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Cidara Therapeutics | 27.96% | 0.72% | 71.32% |
| Sector | Healthcare Stocks | 42.03% | 10.80% | 47.17% |
| Industry | Biotech Stocks | 44.27% | 10.76% | 44.97% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 3.37M | 21.65% | $322.28M |
| Bain capital life sciences investors | 3.02M | 19.43% | $289.29M |
| Point72 asset management | 1.58M | 10.15% | $151.12M |
| Bvf inc/il | 1.41M | 9.10% | $135.42M |
| Vivo capital | 1.31M | 8.44% | $125.58M |
| Vanguard group | 1.23M | 7.92% | $117.85M |
| Blackrock funding, inc. /de | 1.17M | 7.50% | $111.60M |
| Darwin global management | 997.20K | 6.41% | $94.99M |
| Paradigm biocapital advisors lp | 961.16K | 6.18% | $92.04M |
| Vr adviser | 946.79K | 6.09% | $90.66M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 3.02M | 19.20% | $289.29M |
| Acuta capital partners | 141.53K | 14.01% | $13.55M |
| Vivo capital | 1.31M | 10.11% | $125.58M |
| Velan capital investment management lp | 108.40K | 9.75% | $10.38M |
| Superstring capital management lp | 68.46K | 6.46% | $6.56M |
| Bvf inc/il | 1.41M | 5.49% | $135.42M |
| Vr adviser | 946.79K | 5.10% | $90.66M |
| Ra capital management | 3.37M | 3.97% | $322.28M |
| Logos global management lp | 375.00K | 3.22% | $35.91M |
| Patient square capital lp | 121.00K | 3.10% | $11.59M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 961.16K | 2.62% | 961.16K |
| Fmr | 775.53K | 0.00% | 666.82K |
| Bvf inc/il | 1.41M | 5.49% | 627.77K |
| State street | 772.76K | 0.00% | 535.82K |
| Bain capital life sciences investors | 3.02M | 19.20% | 520.31K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| 5am venture management | - | - | -1.13M |
| Tcg crossover management | - | - | -1.01M |
| Blackrock | - | - | -715.41K |
| Adage capital partners gp | 450.00K | 0.07% | -650.00K |
| Commodore capital lp | 585.00K | 2.73% | -590.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Paradigm biocapital advisors lp | 961.16K | 2.62% | 961.16K | $92.04M |
| Fred alger management | 502.88K | 0.19% | 502.88K | $48.16M |
| Holocene advisors, lp | 487.23K | 0.11% | 487.23K | $46.66M |
| Maverick capital | 417.55K | 0.53% | 417.55K | $39.98M |
| Samlyn capital | 307.96K | 0.41% | 307.96K | $29.49M |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -9.00 |
| Dauntless investment group | -54.00 |
| Aster capital management (difc) | -57.00 |
| Cubist systematic strategies | -290.00 |
| Point72 (difc) | -469.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 56 | -53.72% | 4,347,245 | -83.22% | 27 | 0.10% | 41 | -58.16% | 9 | 28.57% |
| Jun 30, 2025 | 121 | 163.04% | 25,911,048 | 172.67% | 166 | 3.71% | 98 | 262.96% | 7 | -22.22% |
| Mar 31, 2025 | 47 | 20.51% | 9,559,387 | 39.46% | 67 | 0.58% | 27 | -10.00% | 9 | 200.00% |
| Dec 31, 2024 | 39 | 44.44% | 6,854,593 | 107.19% | 107 | 4.21% | 30 | 100.00% | 3 | - |
| Sep 30, 2024 | 27 | - | 3,308,428 | 133.57% | 50 | 5.26% | 15 | 150.00% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 592.28K | 2.55% | -13.13K |
| iShares Russell 2000 ETF | 404.28K | 1.59% | - |
| Vanguard US Total Market Shares ETF | 121.55K | 1.11% | - |
| abrdn Healthcare Investors | 179.90K | 0.71% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 159.67K | 0.69% | -69.89K |
| Fidelity Small Cap Index | 168.54K | 0.66% | 168.54K |
| iShares Russell 2000 Value ETF | 147.78K | 0.58% | - |
| Fidelity Select Health Care | 140.00K | 0.55% | 140.00K |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 93.02K | 0.42% | 72.02K |
| Invesco Dorsey Wright SmallCap Momt ETF | 104.73K | 0.41% | 136.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 11, 2025 | Davarpanah Nicole Negar | Chief Medical Officer | Sell | $29.80K |
| Jun 26, 2025 | RA CAPITAL MANAGEMENT, L.P. | Buy | $100.00M | |
| Jun 03, 2025 | Mineo Chrysa | - | Buy | $24.61K |
| Jun 02, 2025 | Mineo Chrysa | - | Buy | $49.28K |
| Mar 11, 2025 | Ward Shane | COO & CLO | Sell | $36.54K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 2 | - |
| 2025 Q1 | - | 2 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 2 |
| 2024 Q2 | 1 | - |
CDTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools